FRANK MCCORMICK
CIK 1257809 · Chairman of Oncology · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$68.84M
Companies
5
Total Filings
37
Lifetime Open-Market Net
-$33.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 767,244 | $85.55 | $65.64M | -$33.91M | 16 | 2026-06-24 |
| BBOT | Director | — | $8.59 | — | $0 | 2 | 2026-06-18 |
| OLMA | Director | 275,373 | $11.62 | $3.20M | $0 | 2 | 2020-11-23 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | — | — | — | $0 | 4 | 2018-06-08 |
| EXEL | Director | — | $56.51 | — | $0 | 8 | 2013-12-09 |
Recent Filings · Page 2 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-24 | BBIO | Notice (144) | −100,000 | -$4.42M | EDGAR |
| 2025-06-24 | BBIO | Grant (A) | +6,589 | $0 | EDGAR |
| 2025-05-09 | BBIO | Gift (G) | −36,000 | $0 | EDGAR |
| 2025-01-08 | BBIO | Gift (G) | −7,400 | $0 | EDGAR |
| 2024-12-27 | BBIO | Gift (G) | −7,400 | $0 | EDGAR |
| 2024-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2023-12-28 | BBIO | Sell (S) | −100,000 | -$4.21M | EDGAR |
| 2023-12-26 | BBIO | Notice (144) | −100,000 | -$4.21M | EDGAR |
| 2023-02-23 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2020-11-23 | OLMA | Conv (C) | +219,217 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.